-

Butterfly Network to Participate in Morgan Stanley 24th Annual Global Healthcare Conference on September 15, 2026

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly”), a pioneer and leader in semiconductor-based ultrasound, cloud software and AI, today announced that it will participate in the Morgan Stanley 24th Annual Global Healthcare Conference in New York City on September 15, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer; and Megan Carlson, SVP, Accounting & Finance – Chief Accounting Officer, will attend and host one-on-one investor meetings.

The Company will participate in a fireside chat at 10:00 AM ET on September 15th. A webcast of the fireside chat will be available in the Events & Presentations section of the Butterfly investor website (https://ir.butterflynetwork.com/events-and-presentations).

About Butterfly Network

Butterfly Network, Inc. (NYSE: BFLY) is driving a digital revolution in ultrasound imaging and sensing with its proprietary Ultrasound-on-Chip™ semiconductor technology and software solutions. Butterfly first proved its technology in the point-of-care ultrasound market – commercializing the world's first single-probe, whole-body portable ultrasound device, which is now on its best-selling, third-generation: Butterfly iQ3™. The Company combines its advanced hardware with cloud software and AI, an enterprise workflow solution (Compass AI™) and other offerings to drive adoption of affordable, accessible ultrasound. Butterfly also enables third-party development of imaging AI apps through Butterfly Garden™, its software development kit and AI marketplace.

In addition to its medical imaging products, Butterfly Embedded™ is the Company's Ultrasound-on-Chip™ licensing and co-development business designed to enable a new wave of ultrasound-enabled technologies across non-competitive healthcare markets and beyond. Through Butterfly Embedded™, partners can build and scale novel ultrasound applications powered by Butterfly's proprietary semiconductor chip and software platform.

Butterfly's innovations have been recognized by Prix Galien USA, Fierce 50, TIME's Best Inventions and Fast Company's World Changing Ideas, among other achievements. To learn more, visit: www.butterflynetwork.com.

Contacts

Investors:
John Doherty
Chief Financial Officer
investors@butterflynetinc.com

Butterfly Network, Inc.

NYSE:BFLY

Release Versions
$Cashtags

Contacts

Investors:
John Doherty
Chief Financial Officer
investors@butterflynetinc.com

Social Media Profiles
More News From Butterfly Network, Inc.

Bridge Neurotech and Butterfly Network Announce Partnership to Develop Fully Non-Invasive Brain-Computer Interface

BURLINGTON, Mass. & REDWOOD CITY, Calif.--(BUSINESS WIRE)--Bridge Neurotech ("Bridge"), which emerged from stealth today with the goal of building a completely non-invasive brain-computer interface (BCI), and Butterfly Network, Inc. ("Butterfly") (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced a research and development agreement through Butterfly Embedded™. Bridge was founded with a mission to make BCIs possible without...

Butterfly Network Appoints Mike Noonen to Board of Directors

NEW YORK & BURLINGTON, Mass.--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of Mike Noonen to its Board of Directors, effective October 9, 2026. Mr. Noonen will serve on the Board's Compensation Committee and Technology Committee. With his appointment, the Board expands to seven directors. Mr. Noonen is a seasoned semiconductor executive with...

Mendaera’s Focalist™ System Now Compatible with Butterfly’s Ultrasound-on-Chip™ Technology

BURLINGTON, Mass. & SAN MATEO, Calif.--(BUSINESS WIRE)--Mendaera, Inc., a healthcare technology company building robotics and intelligence for procedural medicine, and Butterfly Network, Inc. (NYSE: BFLY), a pioneer and leader in semiconductor-based ultrasound, programmable cloud software and AI, today announced that Mendaera’s Focalist™ system is now commercially available with Butterfly Network’s Ultrasound-on-Chip™ imaging technology. Mendaera’s FDA-cleared Focalist system combines handheld...
Back to Newsroom